AccelerAge框架:基于时间到事件数据预测生物年龄的新统计方法
Marije Sluiskes1, Jelle Goeman2, Marian Beekman3
1Medical Statistics, Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands. m.h.sluiskes@lumc.nl.
European journal of epidemiology
|April 6, 2024
概括
这项研究引入了AccelerAge,这是使用加速失效时间模型预测生物年龄的新框架. AccelerAge提供了一个统计学上可靠的方法来评估衰老,改进了现有的生物年龄预测指标.
科学领域:
- 老年学是一门学科.
- 生物统计学 生物统计学
- 基因组学就是基因组学.
背景情况:
- 衰老是一个复杂的过程,有个人的变化,使生物年龄成为一个关键的指标.
- 目前的生物年龄预测器缺乏标准化的运行和强大的统计基础.
- 评估生物年龄预测因素的现有方法往往是不够的.
研究的目的:
- 建议对生物年龄进行全面的操作.
- 引入AccelerAge框架用于预测生物年龄.
- 开发生物年龄预测因子的新型评估措施.
主要方法:
- 使用加速失效时间 (AFT) 模型开发了AccelerAge框架.
- 模拟了衰老预测因素对生存时间的直接影响.
- 使用模拟和真实世界的数据比较AccelerAge预测器与GrimAge预测器 (英国生物银行,莱登长寿研究).
主要成果:
- AccelerAge框架为生物年龄预测提供了一个统计学上合理的方法.
- 新的评估措施为预测器性能提供了更全面的评估.
- 进行的比较证明了AccelerAge在准确评估生物年龄方面的潜力.
结论:
- AccelerAge框架为生物年龄钟建立了一个强大的统计基础.
- 这种方法可以更准确,更可解释地评估个体的衰老.
- 这项研究通过改善生物年龄预测和评估来推进衰老研究领域.
相关概念视频
Introduction To Survival Analysis
228
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
228
Actuarial Approach
77
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
77
Kaplan-Meier Approach
135
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
135
Aging
49
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
49
Comparing the Survival Analysis of Two or More Groups
179
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
179
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345


